# FDA 483 - Tower Pharmacy and Compounding - September 19, 2019

Source: https://www.globalkeysolutions.net/records/483/tower-pharmacy-and-compounding/9cd24748-a1a1-4149-a8a4-cd23d64c75ab

> FDA 483 for Tower Pharmacy and Compounding on September 19, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Tower Pharmacy and Compounding
- Inspection Date: 2019-09-19
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: Tower Pharmacy and Compounding in Mission Viejo, CA, received an FDA Form 483 for significant deficiencies observed during an inspection. The firm was cited for inadequate containment, segregation, and cleaning practices for highly potent drugs, leading to potential cross-contamination. Additionally, the pharmacy routinely used non-pharmaceutical grade components in the formulation of various compounded drug products.

## Related Documents

- [483 - 2019-09-19](https://www.globalkeysolutions.net/records/483/tower-pharmacy-and-compounding/33ed7a6b-ee8d-4cce-add1-b7f89ca81900)
- [145 - 2020-08-11](https://www.globalkeysolutions.net/records/145/tower-pharmacy-and-compounding/41b7443a-ed35-4e5d-8277-b0c2bc909fe7)

## Related Officers

- [Consumer Safety Officer (Inspector)](https://www.globalkeysolutions.net/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)

Company: https://www.globalkeysolutions.net/companies/tower-pharmacy-and-compounding/3c9b4043-5443-4233-b332-44be76bdd719

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6